Publications

Deep generative modeling of the human proteome reveals over a hundred novel genes involved in rare genetic disorders.

Orenbuch R, Kollasch AW, Spinner HD, et al. Deep generative modeling of the human proteome reveals over a hundred novel genes involved in rare genetic disorders. Research square. 2024. doi:10.21203/rs.3.rs-3740259/v1

Heterozygous loss-of-function SMC3 variants are associated with variable growth and developmental features.

Ansari M, Faour KNW, Shimamura A, et al. Heterozygous loss-of-function SMC3 variants are associated with variable growth and developmental features. HGG advances. 2024:100273. doi:10.1016/j.xhgg.2024.100273

GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region.

Ishikawa Y, Tanaka N, Asano Y, et al. GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. Nature communications. 2024;15(1):319. doi:10.1038/s41467-023-44541-z

National prevalence and trends in food labeling awareness, comprehension, usage, and COVID-19 pandemic-related factors in South Korea, 2014-2022.

Choi Y, Kim HJ, Park J, et al. National prevalence and trends in food labeling awareness, comprehension, usage, and COVID-19 pandemic-related factors in South Korea, 2014-2022. Scientific reports. 2024;14(1):2617. doi:10.1038/s41598-024-51948-1

Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis.

Rontogianni MO, Bouras E, Aglago EK, et al. Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis. International journal of obesity (2005). 2024. doi:10.1038/s41366-024-01479-6

Myeloid and lymphoid expression of regulates IL-17A signaling in mice.

Limone F, Couto A, Wang JY, et al. Myeloid and lymphoid expression of regulates IL-17A signaling in mice. Science translational medicine. 2024;16(732):eadg7895. doi:10.1126/scitranslmed.adg7895

Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations.

Ardissino M, Slob EAW, Reddy RK, et al. Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations. European journal of preventive cardiology. 2024. doi:10.1093/eurjpc/zwad402

Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.

Zhang Y, Dron JS, Bellows BK, et al. Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol. JAMA cardiology. 2024. doi:10.1001/jamacardio.2023.5366

Estimating Disorder Probability Based on Polygenic Prediction Using the BPC Approach.

Uffelmann E, Price AL, Posthuma D, Peyrot WJ, , . Estimating Disorder Probability Based on Polygenic Prediction Using the BPC Approach. medRxiv : the preprint server for health sciences. 2024. doi:10.1101/2024.01.12.24301157

Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds.

Wamhoff EC, Ronsard L, Feldman J, et al. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds. Nature communications. 2024;15(1):795. doi:10.1038/s41467-024-44869-0

ӳ����ý

Publications

ӳ��ý